期刊文献+

MicroRNAs与OCT4基因之间的相互作用 被引量:7

Interaction between Micro RNAs and OCT4
下载PDF
导出
摘要 OCT4基因是POU转录因子家族中的一员,它能与含八聚体基序(ATGCAAAT)的DNA结合。OCT4是一个关键的转录因子,在未分化胚胎干细胞中参与维持多能性和自我更新性,在许多种癌症包括肺癌、生殖细胞肿瘤、乳腺癌、宫颈癌、前列腺癌、胃癌、肝癌和卵巢癌中过表达。Micro RNAs(mi RNAs)是一种小的非编码RNA,通过和靶基因m RNA碱基配对来调控m RNA表达,降解m RNA或阻碍蛋白合成。一些mi RNAs被证实在癌细胞中调控干细胞因子如OCT4、NANOG、SOX2和KLF4,进而调控癌细胞的增殖、凋亡、分化、抗药性和免疫性。 Octamer-binding transcription factor 4 (OCT4) belongs to the POU-homeodomain family of tran- scription factors and binds to an octamer motif, ATGCAAAT. OCT4 is the key transcription factor that is involved in the maintenance of pluripotency and self-renewal in undifferentiated embryonic stem (ES) ceUs. OCT4 has been reported to be overexpressed in various cancers including lung, germ ceU tumors, breast, cervix, prostate, gastric, liver, and ovarian cancer. Mi- croRNAs (miRNAs), small non-coding RNAs, modulate mRNA expression through base pairing between seed sequences in miRNA and complementary sequences of the target mRNA, thereby destabilizing mRNA and/or inhibiting protein synthesis. Several miRNAs have been demonstrated to regulate sternness factors such as OCT4, NANOG, SOX2 and KLF4 in cancer cells, thereby modulating the proliferation, apoptosis, differentiation, drug resistance and immunity of cancer ceils.
出处 《中国肺癌杂志》 CAS CSCD 北大核心 2015年第1期55-58,共4页 Chinese Journal of Lung Cancer
基金 天津市高等学校科技发展基金计划项目(No.2006ZD10)资助~~
关键词 MICRORNAS OCT4 肿瘤 胚胎干细胞 多能性 MicroRNAs OCT4 Cancer Embryonic stem cell Pluripotency
  • 相关文献

参考文献1

二级参考文献114

  • 1Jing-Ming Zhai,Xiao-Yu Yin,Xun Hou,Xiao-Yi Hao,Jian-Peng Cai,Li-Jian Liang,Long-Juan Zhang.Analysis of the Genome-Wide DNA Methylation Profile of Side Population Cells in Hepatocellular Carcinoma[J]. Digestive Diseases and Sciences . 2013 (7)
  • 2Chen, Chia-Lin,Tsukamoto, Hidekazu,Liu, Jian-Chang,Kashiwabara, Claudine,Feldman, Douglas,Sher, Linda,Dooley, Steven,French, Samuel W,Mishra, Lopa,Petrovic, Lydia,Jeong, Joseph H,Machida, Keigo.Reciprocal regulation by TLR4 and TGF-[Beta] in tumor-initiating stem-like cells[J]. Journal of Clinical Investigation . 2013 (7)
  • 3Keiki Kumano,Shunya Arai,Masataka Hosoi,Kazuki Taoka,Naoya Takayama,Makoto Otsu,Genta Nagae,Koki Ueda,Kumi Nakazaki,Yasuhiko Kamikubo,Koji Eto,Hiroyuki Aburatani,Hiromitsu Nakauchi,Mineo Kurokawa.Generation of induced pluripotent stem cells from primary chronic myelogenous leukemia patient samples[J]. Blood . 2012 (26)
  • 4Yongsheng Jia,Honglin Liu,Qianshu Zhuang,Shiqing Xu,Zhihua Yang,Jianzhong Li,Jinning Lou,Wenjian Zhang.Tumorigenicity of cancer stem-like cells derived from hepatocarcinomais regulated by microRNA-145[J]. Oncology Reports . 2012 (6)
  • 5Junko Matsuoka,Masakazu Yashiro,Katsunobu Sakurai,Naoshi Kubo,Hiroaki Tanaka,Kazuya Muguruma,Tetsuji Sawada,Masaichi Ohira,Kosei Hirakawa.Role of the Stemness Factors Sox2, Oct3/4, and Nanog in Gastric Carcinoma[J]. Journal of Surgical Research . 2012 (1)
  • 6Verónica Ramos-Mejia,Mario F. Fraga,Pablo Menendez.iPSCs from cancer cells: challenges and opportunities[J]. Trends in Molecular Medicine . 2012 (5)
  • 7Jun Zhang,Na Luo,Yi Luo,Zhiping Peng,Tao Zhang,Shaolin Li.microRNA-150 inhibits human CD133-positive liver cancer stem cells throughnegative regulation of the transcription factor c-Myb[J]. International Journal of Oncology . 2012 (3)
  • 8TetsuhiroChiba,EiichiroSuzuki,MasamitsuNegishi,AtsunoriSaraya,SatoruMiyagi,TakaakiKonuma,SatomiTanaka,MotohisaTada,FumihikoKanai,FumioImazeki,AtsushiIwama,OsamuYokosuka.3‐Deazaneplanocin A is a promising therapeutic agent for the eradication of tumor‐initiating hepatocellular carcinoma cells[J]. Int. J. Cancer . 2012 (11)
  • 9Norikatsu Miyoshi,Hideshi Ishii,Hiroaki Nagano,Naotsugu Haraguchi,Dyah Laksmi Dewi,Yoshihiro Kano,Shinpei Nishikawa,Masahiro Tanemura,Koshi Mimori,Fumiaki Tanaka,Toshiyuki Saito,Junichi Nishimura,Ichiro Takemasa,Tsunekazu Mizushima,Masataka Ikeda,Hirofumi Yamamoto,Mitsugu Sekimoto,Yuichiro Doki,Masaki Mori.Reprogramming of Mouse and Human Cells to Pluripotency Using Mature MicroRNAs[J]. Cell Stem Cell . 2011 (6)
  • 10Rountree C B,Senadheera S,Mato JM, et al.Expansion of liver cancer stem cells during aging in methionine adenosyltrans ferase 1A-deficient mice. Hepatology . 2008

共引文献4

同被引文献76

  • 1Shimada Y, Saji H, Nomura M, et al. Cancer stem cell-related marker expression in lung aden0carcinoma and relevance of histologic subtypes based on IASLC/ATS/ERS classification. Onco Targets Ther. 2013;6:1597-1604.
  • 2Huang Y, Zeng F, Xu L, et al. Anticancer effects of cinnamic acid in lung adenocarcinoma cell line h 1299-derived stem-like cells. Oncol Res. 2013;20(11):499-507.
  • 3Lotz S, Goderie S, Tokas N, et al. Sustained levels of FGF2 maintain undifferentiated stem cell cultures with biweekly feeding. PLoS One. 2013;8(2):e56289.
  • 4Wu X, Chen H, Wang X. Can lung cancer stem cells be targeted for therapies. Cancer Treat Rev. 2012;38(6): 580-588.
  • 5Fan X, Khaki L, Zhu TS, et al. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts.Stem Cells. 2010;28(1 ):5-16.
  • 6Li Z. CD133: a stem cell biomarker and beyond. Exp Hematol Oncol. 2013;2(1):17.
  • 7Akita M, Tanaka K, Matsumoto S, et al. Detection of the Hematopoietic Stem and Progenitor Cell Marker CD133 during Angiogenesis in Three-Dimensional Collagen Gel Culture. Stem Cells Int. 2013;2013:927403.
  • 8Liu D, Zhou P, Zhang L, et al. HPV16 activates the promoter of Oct4 gene by sequestering HDAC1 from repressor complex to target it to proteasomal degradation. Med Hypotheses. 2012;79(4):531-534.
  • 9Karoubi G, Gugger M, Schmid R, et al. OCT4 expression in human non-small cell lung cancer: implications for therapeutic intervention. Interact Cardiovasc Thorac Surg. 2009;8(4): 393-397.
  • 10Hu T, Liu S, Breiter DR, et al. Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis.Cancer Res. 2008: 68(16):6533-6540.

引证文献7

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部